Table 1.
Demographic and clinical characteristics of the study population.
| IDA (n = 124) | |
|---|---|
| Age, y | 49.96 ± 12.81 |
| Sex, female, n (%) | 109 (87.9) |
| BMI, kg/m2 | 23.24 ± 3.64 |
| Previous illness, yes, n (%) | 58 (48.7) |
| Current medications, yes, n (%) | 54 (45.4) |
| Hemoglobin, g/dL | 9.34 ± 1.70 |
| Iron, μg/dL | 29.93 ± 31.62 |
| TIBC, μg/dL | 419.24 ± 60.83 |
| TSAT, % | 7.41 ± 7.87 |
| Ferritin, ng/mL | 10.29 ± 23.84 |
| IDA duration, y | 3.14 ± 2.01 |
| IDA treatment, yes, n (%) | 18 (14.5) |
| IDA cause, n (%) | |
| Gastric ulcer with bleeding | 44 (35.5) |
| Hypermenorrhea | 26 (20.9) |
| Stomach cancer operation | 4 (3.2) |
| Diffuse large B-cell lymphoma | 2 (1.6) |
| Unknown | 48 (38.7) |
BMI = body mass index, IDA = iron deficiency anemia, TIBC = total iron-binding capacity, TSAT = transferrin saturation.